Mainz Biomed N.V (MYNZ) Gross Profit: 2019-2024
Historic Gross Profit for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to $574,883.
- Mainz Biomed N.V's Gross Profit rose 11.98% to $9.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $31.3 million, marking a year-over-year increase of 254.62%. This contributed to the annual value of $574,883 for FY2024, which is 12.80% up from last year.
- According to the latest figures from FY2024, Mainz Biomed N.V's Gross Profit is $574,883, which was up 12.80% from $509,659 recorded in FY2023.
- In the past 5 years, Mainz Biomed N.V's Gross Profit ranged from a high of $574,883 in FY2024 and a low of $123,085 during FY2020.
- Over the past 3 years, Mainz Biomed N.V's median Gross Profit value was $509,659 (recorded in 2023), while the average stood at $422,231.
- Data for Mainz Biomed N.V's Gross Profit shows a peak YoY surged of 300.89% (in 2020) over the last 5 years.
- Over the past 5 years, Mainz Biomed N.V's Gross Profit (Yearly) stood at $123,085 in 2020, then spiked by 44.31% to $177,622 in 2021, then climbed by 2.55% to $182,151 in 2022, then skyrocketed by 179.80% to $509,659 in 2023, then climbed by 12.80% to $574,883 in 2024.